رجوع
نطاق اليوم
KWD 10.88
KWD 10.88
نطاق 52 أسبوعًا
KWD 3.28
KWD 10.88
حجم التداول
500
متوسط 50 يوم / 200 يوم
KWD 8.14
/
KWD 4.95
الإغلاق السابق
KWD 10.88
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 361.3 | 0.3 |
| P/B | 7.9 | 3.0 |
| ROE % | 2.2 | 3.7 |
| Net Margin % | 2.3 | 3.8 |
| Rev Growth 5Y % | 205.9 | 10.0 |
| D/E | 0.9 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
-KWD 0.34
-KWD 0.52 – -KWD 0.18
|
63.12M | 1 |
| FY2028 |
KWD 0.17
KWD 0.09 – KWD 0.27
|
84.02M | 1 |
| FY2027 |
KWD 0.60
KWD 0.33 – KWD 0.93
|
98.74M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-04-24 | -KWD 0.24 | -KWD 0.58 | -138.3% |
| 2024-09-19 | KWD 0.33 | KWD 0.50 | +51.2% |
| 2024-04-04 | KWD 1.35 | -KWD 0.16 | -112.0% |
| 2023-12-30 | N/A | -KWD 0.15 | — |
| 2023-09-20 | -KWD 0.39 | -KWD 0.42 | -7.6% |
| 2023-04-13 | -KWD 1.08 | -KWD 0.27 | +75.2% |
| 2022-12-31 | N/A | -KWD 0.12 | — |
| 2022-09-28 | -KWD 0.23 | -KWD 0.21 | +9.0% |
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 205.92% annually over 5 years — strong growth
ROE of 2.20% is below average
Generating 14.22M in free cash flow
P/E of 361.25 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 71.36%
Cash machine — converts 943.66% of earnings into free cash flow
النمو
Revenue Growth (5Y)
205.92%
Revenue (1Y)134.56%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
2.20%
ROIC1.87%
Net Margin2.25%
Op. Margin4.90%
الأمان
Debt / Equity
0.90
Current Ratio1.23
Interest Coverage0.69
التقييم
P/E Ratio
361.25
Forward P/EN/A
P/B Ratio7.86
EV/EBITDA159.93
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 134.56% | Revenue Growth (3Y) | 82.15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 205.92% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67.00M | Net Income (TTM) | 1.51M |
| ROE | 2.20% | ROA | 1.00% |
| Gross Margin | 99.55% | Operating Margin | 4.90% |
| Net Margin | 2.25% | Free Cash Flow (TTM) | 14.22M |
| ROIC | 1.87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.90 | Current Ratio | 1.23 |
| Interest Coverage | 0.69 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 361.25 | Forward P/E | N/A |
| P/B Ratio | 7.86 | P/S Ratio | 8.13 |
| PEG Ratio | -1.08 | Forward PEG | N/A |
| EV/EBITDA | 159.93 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 2.61% | ||
| Market Cap | 544.40M | Enterprise Value | 524.75M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 67.00M | 28.57M | 20.20M | 80.07M | 765,000.0 |
| Net Income | 1.51M | -28.89M | -23.72M | 67.26M | -101.22M |
| EPS (Diluted) | 0.03 | -0.58 | -0.48 | 1.23 | -2.60 |
| Gross Profit | 66.70M | 28.22M | 19.95M | 79.91M | 563,000.0 |
| Operating Income | 3.28M | -26.58M | -27.29M | 31.82M | -82.90M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 151.42M | 173.87M | 215.54M | 281.72M | 198.61M |
| Total Liabilities | 82.20M | 105.92M | 121.01M | 162.62M | 214.78M |
| Shareholders' Equity | 69.22M | 67.95M | 94.53M | 119.10M | -16.16M |
| Total Debt | 62.13M | 70.18M | 75.28M | 74.24M | 185.69M |
| Cash & Equivalents | 81.79M | 77.79M | 136.00M | 258.76M | 171.03M |
| Current Assets | 92.77M | 113.12M | 158.46M | 268.10M | 184.72M |
| Current Liabilities | 75.16M | 38.48M | 39.37M | 62.84M | 31.07M |